News

Caire, which operates under Chart’s BioMedical segment, has completed the previously announced acquisition of Covidien’s oxygen therapy business, including the design, manufacturing, and sales and service functions worldwide.

Bayer Schering Pharma (Bayer Schering) has reported the enrollment of first patient in an international clinical Phase III trial to evaluate the efficacy and safety of Florbetaben (BAY

Xencor has licensed its XmAb and Xtend technology platforms to Centocor Research & Development (Centocor) for the optimisation of Centocor’s antibody drug candidates. The license follows a 2009

QRxPharma has initiated registration in the pivotal (Study 008) Phase 3 study of MoxDuoIR for moderate to severe acute pain. The company expects to complete dosing by close

GlaxoSmithKline (GSK) has filed its vaccine for the prevention of rotavirus gastroenteritis (approved as Rotarix in a number of countries outside of Japan). The company claims that the

Dishman Netherlands has oppened its containment cGMP laboratory on November 27, 2009. It was inaugrated by Jay Vyas, chairman and owner of the Indian Dishman Group. Important attendees

eHealthSource.com has launched the first online shopping site dedicated to products approved for Flexible Spending Account or Health Savings Account (FSA/HSA) claims. The site is also the first

Cromoz will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation

Kiadis Pharma (Kiadis) has reported the first patient enrollment in its multinational registration clinical trial with Atir. The study is designed to show reduction in Transplant Related Mortality